brought to you byLaboratorio Nacional de Engenharia Civil – LNEC
Skip main navigation
ReviewOpen AccessOpen Access license

Rosmarinus officinalis L.: an update review of its phytochemistry and biological activity

    Joana M Andrade

    CBIOS – Research Center for Biosciences & Health technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749–024 Lisboa, Portugal

    ,
    Célia Faustino

    iMed.ULisboa – Research Institute for Medicines, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649–003 Lisboa, Portugal

    ,
    Catarina Garcia

    CBIOS – Research Center for Biosciences & Health technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749–024 Lisboa, Portugal

    ,
    Diogo Ladeiras

    CBIOS – Research Center for Biosciences & Health technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749–024 Lisboa, Portugal

    ,
    Catarina P Reis

    iMed.ULisboa – Research Institute for Medicines, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649–003 Lisboa, Portugal

    Biophysics & Biomedical Engineering Institute (IBEB), Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1749–016 Lisbon, Portugal

    &
    Patrícia Rijo

    *Author for correspondence: Tel.: +351 217 515 500;

    E-mail Address: patricia.rijo@ulusofona.pt

    CBIOS – Research Center for Biosciences & Health technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749–024 Lisboa, Portugal

    iMed.ULisboa – Research Institute for Medicines, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649–003 Lisboa, Portugal

    Published Online:https://doi.org/10.4155/fsoa-2017-0124

    The worldwide interest in the use of medicinal plants has been growing, and its beneficial effects being rediscovered for the development of new drugs. Based on their vast ethnopharmacological applications, which inspired current research in drug discovery, natural products can provide new and important leads against various pharmacological targets. This work pioneers an extensive and an updated literature review on the current state of research on Rosmarinus officinalis L., elucidating which compounds and biological activities are the most relevant. Therefore, a search was made in the databases PubMed, ScienceDirect and Web of Science with the terms ‘rosemary’, ‘Rosmarinus officinalis’, ‘rosmarinic acid’ ‘carnosol’ and ‘carnosic acid’, which included 286 articles published since 1990 about rosemary's pharmacological activities and their isolated compounds. According to these references, there has been an increasing interest in the therapeutic properties of this plant, regarding carnosic acid, carnosol, rosmarinic acid and the essential oil. The present manuscript provides an updated review upon the most reported activities on R. officinalis and its active constituents.

    Lay abstract

    The worldwide interest in the use of medicinal plants has been growing, and their beneficial effects being rediscovered for the development of new drugs. Actually, current research in drug discovery has been inspired on the vast ethnopharmacological applications of natural products, providing new and important leads against various pharmacological targets.

    In this work, an updated literature review is presented to clarify the current state of research on Rosmarinus officinalis L., elucidating its constituents and their most relevant biological activities. Therefore, this work provides an updated review upon the most reported medicinal properties, namely, antitumoral, anti-inflammatory, analgesic, neurodegenerative, endocrinal, anti-infective and antioxidant.

    References

    • 1 Batanouny KH, Aboutabl E, Shabana MC, Soliman F. Wild Medicinal Plants in Egypt: An Inventory to Support Conservation and Sustainable Use. Academy of Scientific Research & Technology, Cairo, Egypt (1999).Google Scholar
    • 2 Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830(6), 3670–3695 (2013).Crossref, Medline, CASGoogle Scholar
    • 3 Mukherjee PK, N SK, Heinrich M. Plant Made Pharmaceuticals (PMPs) – development of natural health products from bio-diversity. Indian J. Pharm. Educ. Res. 42(2), 113–121 (2008).Google Scholar
    • 4 Jardak M, Elloumi-Mseddi J, Aifa S, Mnif S. Chemical composition, anti-biofilm activity and potential cytotoxic effect on cancer cells of Rosmarinus officinalis L. essential oil from Tunisia. Lipids Health Dis. 16(1), 190 (2017).Crossref, MedlineGoogle Scholar
    • 5 Habtemariam S. The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer's disease. Evid. Based Complement. Alternat. Med. 2016, 2680409 (2016).Crossref, MedlineGoogle Scholar
    • 6 Mendonça-Filho RR. Bioactive phytocompounds: new approaches in the phytosciences. In: Modern Phytomedicine: Turning Medicinal Plants into Drugs. Ahmad I, Aqil F, Owais M (Eds). John Wiley & Sons, Weinheim, Germany, 1–24 (2006).CrossrefGoogle Scholar
    • 7 Swain T. Plants in the Development of Modern Medicine. Harvard University Press, Cambridge, Massachusetts (1972).CrossrefGoogle Scholar
    • 8 Cragg GM, Newman DJ. Drugs from nature: past achievements, future prospects. In: Ethnomedicine and Drug Discovery. Iwu M, Wootton J (Eds). Elsevier, New York, USA, 23–37 (2002).CrossrefGoogle Scholar
    • 9 Heinrich M, Barnes J, Gibbons S, Williamson E. Fundamentals of Pharmacognosy and Phytotherapy (2nd Edition). Elsevier Health Sciences, Edinburgh, UK.Google Scholar
    • 10 Rotblatt M. Herbal medicine: expanded commission E monographs. Ann. Intern. Med. 133(6), 487 (2000).CrossrefGoogle Scholar
    • 11 Food Standards Agency. Current EU approved additives and their E Numbers. Food Standards Agency (2016). www.food.gov.uk/science/additives/enumberlist.Google Scholar
    • 12 Mohamed I, Shuid A, Borhanuddin B, Fozi N. The application of phytomedicine in modern drug development. Internet J. Herb. Plant Med. 1(2), 14278 (2012).Google Scholar
    • 13 Cordell GA, Colvard MD. Some thoughts on the future of ethnopharmacology. J. Ethnopharmacol. 100(1–2), 5–14 (2005).Crossref, MedlineGoogle Scholar
    • 14 Calixto JB. Twenty-five years of research on medicinal plants in Latin America: a personal view. J. Ethnopharmacol. 100(1–2), 131–134 (2005).Crossref, MedlineGoogle Scholar
    • 15 Rates SMK. Plants as source of drugs. Toxicon 39(5), 603–613 (2001).Crossref, Medline, CASGoogle Scholar
    • 16 Salim AA, Chin Y-W, Kinghorn AD. Drug discovery from plants. In: Bioactive Molecules and Medicinal Plants. Ramawat KG, Merillon JM (Eds). Springer, Berlin and Heidelberg, Germany, 1–24 (2008).CrossrefGoogle Scholar
    • 17 Bandaranayake WM. Quality control, screening, toxicity, and regulation of herbal drugs. In: Modern Phytomedicine: Turning Medicinal Plants into Drugs. Ahmad I, Aqil F, Owais M (Eds). John Wiley & Sons, Weinheim, Germany, 25–57 (2006).CrossrefGoogle Scholar
    • 18 Rout SP, Choudary KA, Kar DM, Das L, Jain A. Plants in traditional medicinal system – future source of new drugs. Int. J. Pharm. Pharm. Sci. 1(1), 1–23 (2009).Google Scholar
    • 19 Samuelsson G, Bohlin L. Drugs of Natural Origin: A Treatise of Pharmacognosy (6th Edition). Swedish Pharmaceutical Press, Stockholm, Sweden (2001).Google Scholar
    • 20 Kinne-Saffran E, Kinne RKH. Vitalism and synthesis of urea. Am. J. Nephrol. 19(2), 290–294 (1999).Crossref, Medline, CASGoogle Scholar
    • 21 Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 78(5), 431–441 (2005).Crossref, Medline, CASGoogle Scholar
    • 22 Keservani RK, Sharma AK, Kesharwani RK, IGI Global. Phytopharmaceuticals and its applications in therapy. In: Recent Advances in Drug Delivery Technology. IGI Global, Delhi, India, 202–229 (2017).CrossrefGoogle Scholar
    • 23 Iwu MM. Therapeutic agents from ethnomedicine. In: Ethnomedicine and Drug Discovery. Iwu M, Wootton J (Eds). Elsevier, New York, USA, 1–22 (2002).CrossrefGoogle Scholar
    • 24 Hamburger M, Hostettmann K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 30(12), 3864–3874 (1991).Crossref, CASGoogle Scholar
    • 25 Oyebode O, Kandala N-B, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 31(8), 984–991 (2016).Crossref, MedlineGoogle Scholar
    • 26 Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. Williams & Wilkins, MD, USA.Google Scholar
    • 27 Krogsgaard-Larsen P, Christensen SB, Kofod H. The role of Medicinal plants in drug development. In: Natural Products and Drug Development. Munksgaard, Copenhagen, Denmark, 34–45 (1994).Google Scholar
    • 28 Raskin I, Ribnicky DM, Komarnytsky S et al. Plants and human health in the twenty-first century. Trends Biotechnol. 20(12), 522–531 (2002).Crossref, Medline, CASGoogle Scholar
    • 29 Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 109(Suppl. 1), 69–75 (2001).Crossref, Medline, CASGoogle Scholar
    • 30 Katiyar C, Gupta A, Kanjilal S, Katiyar S. Drug discovery from plant sources: an integrated approach. Ayu 33(1), 10–19 (2012).Crossref, MedlineGoogle Scholar
    • 31 Badal McCreath S, Delgoda R. Metabolomics approach in pharmacognosy. In: Pharmacognosy: Fundamentals, Applications and Strategies. Badal McCreath S, Delgoda R (Eds). Academic Press, London, UK, 597–630 (2017).Google Scholar
    • 32 Ahmad I, Aqil F, Ahmad F, Owais M. Herbal medicines: prospects and constraints. In: Modern Phytomedicine: Turning Medicinal Plants into Drugs. Ahmad I, Aqil F, Owais M (Eds). John Wiley & Sons, Weinheim, Germany, 59–77 (2006).CrossrefGoogle Scholar
    • 33 Kamboj A. Analytical evaluation of herbal drugs. In: Drug Discovery Research in Pharmacognosy. Vallisuta O (Ed.). InTech, Rijeka, Croatia, 23–60 (2012).CrossrefGoogle Scholar
    • 34 Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann. Intern. Med. 135(8 Pt 1), 594–600 (2001).Crossref, Medline, CASGoogle Scholar
    • 35 Naghibi F, Mosaddegh M, Motamed SM, Ghorbani A. Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology. Iran. J. Pharm. Res. 63–79 (2005).Google Scholar
    • 36 Raja RR. Medicinally potential plants of Labiatae (Lamiaceae) family: an overview. Res. J. Med. Plant. 6(3), 203–213 (2012).CrossrefGoogle Scholar
    • 37 Wagstaff SJ, Hickerson L, Spangler R, Reeves PA, Olmstead RG. Phylogeny in Labiatae sl, inferred from cpDNA sequences. Plant Syst. Evol. 209(3–4), 265–274 (1998).Crossref, CASGoogle Scholar
    • 38 Begum A, Sandhya S, Shaffath Ali S, Vinod KR, Reddy S, Banji D. An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae). Acta Sci. Pol. Technol. Aliment. 12(1), 61–73 (2013).Medline, CASGoogle Scholar
    • 39 Al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J. Exp. Biol. 37(2), 124–130 (1999).Medline, CASGoogle Scholar
    • 40 WHO. WHO monographs on selected medicinal plants. World Health Organization, Geneva. http://apps.who.int/medicinedocs/en/d/Js2200e/.Google Scholar
    • 41 Comissão Permanente da Farmacopeia Portuguesa. Farmacopeia Portuguesa (7th Edition). Ministério da Saúde, Lisbon, Portugal (2003).Google Scholar
    • 42 Badal McCreath S, Delgoda R. Pharmacognosy: fundamentals, applications and strategies. Academic Press, London, UK (2016).Google Scholar
    • 43 Handa SS. Extraction technologies for medicinal and aromatic plants. International Centre for Science and High Technology. www.unido.org/sites/default/files/2009-10/Extraction_technologies_for_medicinal_and_aromatic_plants_0.pdf.Google Scholar
    • 44 Gupta A, Naraniwal M, Kothari V. Modern extraction methods for preparation of bioactive plant extracts. Int. J. Appl. Nat. Sci. 1(1), 8–26 (2012).Google Scholar
    • 45 Azmir J, Zaidul ISM, Rahman MM et al. Techniques for extraction of bioactive compounds from plant materials: a review. J. Food Eng. 117(4), 426–436 (2013).Crossref, CASGoogle Scholar
    • 46 Lovkova MY, Buzuk GN, Sokolova SM, Kliment'eva NI. Chemical features of medicinal plants (review). Appl. Biochem. Microbiol. 37(3), 229–237 (2001).Crossref, CASGoogle Scholar
    • 47 Faixová Z, Faix S. Biological effects of rosemary (Rosmarinus officinalis L.) essential oil (a review). Folia Vet. 52, 135–139 (2008).CASGoogle Scholar
    • 48 Ulbricht C, Abrams TR, Brigham A et al. An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the Natural Standard Research Collaboration. J. Diet. Suppl. 7(4), 351–413 (2010).Crossref, MedlineGoogle Scholar
    • 49 Aumeeruddy-Elalfi Z, Gurib-Fakim A, Mahomoodally MF. Chemical composition, antimicrobial and antibiotic potentiating activity of essential oils from 10 tropical medicinal plants from Mauritius. J. Herb. Med. 6(2), 88–95 (2016).CrossrefGoogle Scholar
    • 50 Aumeeruddy-Elalfi Z, Gurib-Fakim A, Mahomoodally F. Antimicrobial, antibiotic potentiating activity and phytochemical profile of essential oils from exotic and endemic medicinal plants of Mauritius. Ind. Crops Prod. 71, 197–204 (2015).Crossref, CASGoogle Scholar
    • 51 Bozin B, Mimica-Dukic N, Samojlik I, Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J. Agric. Food Chem. 55(19), 7879–7885 (2007).Crossref, Medline, CASGoogle Scholar
    • 52 Evans WC. Trease and Evans’ Pharmacognosy (16th Edition). Elsevier Health Sciences, Edinburgh, UK (2009).Google Scholar
    • 53 Wichtl M. Herbal Drugs and Phytopharmaceuticals (3rd Edition). Medpharm, Stuttgart, Germany (2004).Google Scholar
    • 54 Doughari JH. Phytochemicals: extraction methods, basic structures and mode of action as potential chemotherapeutic agents. In: Phytochemicals – A Global Perspective of Their Role in Nutrition and Health. Rao V (Ed.). InTech, Rijeka, Croatia, 1–32 (2012).Google Scholar
    • 55 Posadas SJ, Caz V, Largo C et al. Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats. Exp. Gerontol. 44(6–7), 383–389 (2009).Crossref, Medline, CASGoogle Scholar
    • 56 Zhang Y, Adelakun TA, Qu L et al. New terpenoid glycosides obtained from Rosmarinus officinalis L. aerial parts. Fitoterapia. 99, 78–85 (2014).Crossref, Medline, CASGoogle Scholar
    • 57 Calvo MI, Akerreta S, Cavero RY. Pharmaceutical ethnobotany in the Riverside of Navarra (Iberian Peninsula). J. Ethnopharmacol. 135(1), 22–33 (2011).Crossref, Medline, CASGoogle Scholar
    • 58 Bakirel T, Bakirel U, Keleş OU, Ulgen SG, Yardibi H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J. Ethnopharmacol. 116(1), 64–73 (2008).Crossref, MedlineGoogle Scholar
    • 59 Yu M-H, Choi J-H, Chae I-G et al. Suppression of LPS-induced inflammatory activities by Rosmarinus officinalis L. Food Chem. 136(2), 1047–1054 (2013).Crossref, Medline, CASGoogle Scholar
    • 60 Takaki I, Bersani-Amado LE, Vendruscolo A et al. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J. Med. Food. 11(4), 741–746 (2008).Crossref, Medline, CASGoogle Scholar
    • 61 Cheung S, Tai J. Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol. Rep. 17(6), 1525–1531 (2007).MedlineGoogle Scholar
    • 62 Tai J, Cheung S, Wu M, Hasman D. Antiproliferation effect of rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Phytomedicine 19(5), 436–443 (2012).Crossref, Medline, CASGoogle Scholar
    • 63 Yesil-Celiktas O, Sevimli C, Bedir E, Vardar-Sukan F. Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant foods Hum. Nutr. 65(2), 158–163 (2010).Crossref, Medline, CASGoogle Scholar
    • 64 Pérez-Fons L, Garzón MT, Micol V. Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order. J. Agric. Food Chem. 58(1), 161–171 (2010).Crossref, Medline, CASGoogle Scholar
    • 65 Romo Vaquero M, Yáñez-Gascón M-J, García Villalba R et al. Inhibition of gastric lipase as a mechanism for body weight and plasma lipids reduction in Zucker rats fed a rosemary extract rich in carnosic acid. PLoS ONE 7(6), e39773 (2012).Crossref, MedlineGoogle Scholar
    • 66 Visanji JM, Thompson DG, Padfield PJ. Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett. 237(1), 130–136 (2006).Crossref, Medline, CASGoogle Scholar
    • 67 Sancheti G, Goyal P. Modulatory influence of Rosemarinus officinalis on DMBA-induced mouse skin tumorigenesis. Asian Pacific J. Cancer Prev. 7(2), 331–335 (2006).MedlineGoogle Scholar
    • 68 Prasad S, Yadav VR, Kannappan R, Aggarwal BB. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK. J. Biol. Chem. 286(7), 5546–5557 (2011).Crossref, Medline, CASGoogle Scholar
    • 69 González-Vallinas M, Molina S, Vicente G et al. Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer. PLoS ONE 9(6), e98556 (2014).Crossref, MedlineGoogle Scholar
    • 70 Xiang Q, Ma Y, Dong J, Shen R. Carnosic acid inducesapoptosis associated with mitochondrial dysfunction and Akt inactivation in HepG2 cells. Int. J. Food Sci. Nutr. 7486, 1–9 (2014).Google Scholar
    • 71 Kar S, Palit S, Ball WB, Das PK. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 17(7), 735–747 (2012).Crossref, Medline, CASGoogle Scholar
    • 72 Huang MT, Ho CT, Wang ZY et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54(3), 701–708 (1994).Medline, CASGoogle Scholar
    • 73 Dörrie J, Sapala K, Zunino SJ. Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett. 170(1), 33–39 (2001).Crossref, Medline, CASGoogle Scholar
    • 74 Tsai C, Lin C, Wang Y. Carnosic acid induces the NAD(P)H: quinone oxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 pathway. J. Nutr. 141(12), 2119–2125 (2011).Crossref, Medline, CASGoogle Scholar
    • 75 Barni MV, Carlini MJ, Cafferata EG, Puricelli L, Moreno S. Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol. Rep. 27(4), 1041–1048 (2012).Crossref, Medline, CASGoogle Scholar
    • 76 Bai N, He K, Roller M et al. Flavonoids and phenolic compounds from Rosmarinus officinalis. J. Agric. Food Chem. 58(9), 5363–5367 (2010).Crossref, Medline, CASGoogle Scholar
    • 77 González-Vallinas M, Molina S, Vicente G et al. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol. Res. 72, 61–68 (2013).Crossref, Medline, CASGoogle Scholar
    • 78 Theoduloz C, Pertino MW, Rodríguez Ja, Schmeda-Hirschmann G. Gastroprotective effect and cytotoxicity of carnosic acid derivatives. Planta Med. 77(9), 882–887 (2011).Crossref, Medline, CASGoogle Scholar
    • 79 Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett. 104(1), 43–48 (1996).Crossref, Medline, CASGoogle Scholar
    • 80 Lee K-G, Shibamoto T. Determination of antioxidant potential of volatile extracts isolated from various herbs and spices. J. Agric. Food Chem. 50(17), 4947–4952 (2002).Crossref, Medline, CASGoogle Scholar
    • 81 Botsoglou N, Taitzoglou I, Zervos I, Botsoglou E, Tsantarliotou M, Chatzopoulou PS. Potential of long-term dietary administration of rosemary in improving the antioxidant status of rat tissues following carbon tetrachloride intoxication. Food Chem. Toxicol. 48(3), 944–950 (2010).Crossref, Medline, CASGoogle Scholar
    • 82 Benincá JP, Dalmarco JB, Pizzolatti MG, Fröde TS. Analysis of the anti-inflammatory properties of Rosmarinus officinalis L. in mice. Food Chem. 124(2), 468–475 (2011).Crossref, CASGoogle Scholar
    • 83 Leal PF, Braga MEM, Sato DN, Carvalho JE, Marques MOM, Meireles MAA. Functional properties of spice extracts obtained via supercritical fluid extraction. J. Agric. Food Chem. 51(9), 2520–2525 (2003).Crossref, Medline, CASGoogle Scholar
    • 84 Aherne SA, Kerry JP, O'Brien NM. Effects of plant extracts on antioxidant status and oxidant-induced stress in Caco-2 cells. Br. J. Nutr. 97(2), 321–328 (2007).Crossref, Medline, CASGoogle Scholar
    • 85 Gutiérrez ME, García AF, Africa de Madariaga M, Sagrista ML, Casadó FJ, Mora M. Interaction of tocopherols and phenolic compounds with membrane lipid components: evaluation of their antioxidant activity in a liposomal model system. Life Sci. 72(21), 2337–2360 (2003).Crossref, Medline, CASGoogle Scholar
    • 86 Lo A, Liang Y, Lin-Shiau S-Y, Ho C, Lin J. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages. Carcinogenesis 23(6), 983–991 (2002).Crossref, Medline, CASGoogle Scholar
    • 87 Klancnik A, Guzej B, Kolar MH, Abramovic H, Mozina SS. In vitro antimicrobial and antioxidant activity of commercial rosemary extract formulations. J. Food Prot. 72(8), 1744–1752 (2009).Crossref, Medline, CASGoogle Scholar
    • 88 Beretta G, Artali R, Facino RM, Gelmini F. An analytical and theoretical approach for the profiling of the antioxidant activity of essential oils: the case of Rosmarinus officinalis L. J. Pharm. Biomed. Anal. 55(5), 1255–1264 (2011).Crossref, Medline, CASGoogle Scholar
    • 89 Zeng HH, Tu PF, Zhou K, Wang H, Wang BH, Lu JF. Antioxidant properties of phenolic diterpenes from Rosmarinus officinalis. Acta Pharmacol. Sin. 22(12), 1094–1098 (2001).Medline, CASGoogle Scholar
    • 90 del Baño MJ, Lorente J, Castillo J et al. Phenolic diterpenes, flavones, and rosmarinic acid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Antioxidant activity. J. Agric. Food Chem. 51(15), 4247–4253 (2003).Crossref, Medline, CASGoogle Scholar
    • 91 Rašković A, Milanović I, Pavlović N, Ćebović T, Vukmirović S, Mikov M. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complement. Altern. Med. 14, 225 (2014).Crossref, MedlineGoogle Scholar
    • 92 Kačániová M, Vukovič N, Horská E et al. Antibacterial activity against Clostridium genus and antiradical activity of the essential oils from different origin. J. Environ. Sci. Health. B 49(7), 505–512 (2014).Crossref, Medline, CASGoogle Scholar
    • 93 Wang W, Li N, Luo M, Zu Y, Efferth T. Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules 17(3), 2704–2713 (2012).Crossref, Medline, CASGoogle Scholar
    • 94 Qabaha K. Antimicrobial and free radical scavenging activities of five palestinian medicinal plants. African J. Tradit. Complement. Altern. Med. 10(4), 101–108 (2013).MedlineGoogle Scholar
    • 95 Petrolini FVB, Lucarini R, de Souza MGM, Pires RH, Cunha WR, Martins CHG. Evaluation of the antibacterial potential of Petroselinum crispum and Rosmarinus officinalis against bacteria that cause urinary tract infections. Brazilian J. Microbiol. 44(3), 829–834 (2013).Crossref, MedlineGoogle Scholar
    • 96 Luqman S, Dwivedi GR, Darokar MP, Kalra A, Khanuja SPS. Potential of rosemary oil to be used in drug-resistant infections. Altern. Ther. Health Med. 13(5), 54–59 (2007).MedlineGoogle Scholar
    • 97 Jiang Y, Wu N, Fu Y-J et al. Chemical composition and antimicrobial activity of the essential oil of rosemary. Environ. Toxicol. Pharmacol. 32(1), 63–68 (2011).Crossref, Medline, CASGoogle Scholar
    • 98 Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review. Evid Based Complement Alternat Med. 2016 (ID 3012462), 1–21 (2016).CrossrefGoogle Scholar
    • 99 Shin H-B, Choi M-S, Ryu B et al. Antiviral activity of carnosic acid against respiratory syncytial virus. Virol. J. 10(1), 303 (2013).Crossref, MedlineGoogle Scholar
    • 100 da Rosa JS, Facchin BM, Bastos J et al. Systemic administration of Rosmarinus officinalis attenuates the inflammatory response induced by carrageenan in the mouse model of pleurisy. Planta Med. 79(17), 1605–1614 (2013).Crossref, MedlineGoogle Scholar
    • 101 Backhouse N, Rosales L, Apablaza C et al. Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae. J. Ethnopharmacol. 116(2), 263–269 (2008).Crossref, Medline, CASGoogle Scholar
    • 102 Peng C-H, Su J-D, Chyau C-C et al. Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Biosci. Biotechnol. Biochem. 71(9), 2223–2232 (2007).Crossref, Medline, CASGoogle Scholar
    • 103 Zanella CA, Treichel H, Cansian RL, Roman SS. The effects of acute administration of the hydroalcoholic extract of rosemary (Rosmarinus officinalis L.) (Lamiaceae) in animal models of memory. Brazilian J. Pharm. Sci. 48(3), 389–397 (2012).CrossrefGoogle Scholar
    • 104 Martínez AL, González-Trujano ME, Chávez M, Pellicer F. Antinociceptive effectiveness of triterpenes from rosemary in visceral nociception. J. Ethnopharmacol. 142(1), 28–34 (2012).Crossref, Medline, CASGoogle Scholar
    • 105 Rosenbaum CC, O'Mathúna DP, Chavez M, Shields K. Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altern. Ther. Health Med. 16(2), 32–40 (2010).MedlineGoogle Scholar
    • 106 Kuo C-F, Su J-D, Chiu C-H et al. Anti-inflammatory effects of supercritical carbon dioxide extract and its isolated carnosic acid from Rosmarinus officinalis leaves. J. Agric. Food Chem. 59(8), 3674–3685 (2011).Crossref, Medline, CASGoogle Scholar
    • 107 Chae IG, Yu MH, Im N-K et al. Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells. J. Med. Food. 15(10), 879–886 (2012).Crossref, MedlineGoogle Scholar
    • 108 Yu Y-M, Lin H-C, Chang W-C. Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. Br. J. Nutr. 100(4), 731–738 (2008).Crossref, Medline, CASGoogle Scholar
    • 109 Lucarini R, Bernardes WA, Ferreira DS et al. In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid and its acetyl ester derivative. Pharm. Biol. 51(9), 1087–1090 (2013).Crossref, Medline, CASGoogle Scholar
    • 110 Lukaczer D, Darland G, Tripp M et al. A Pilot trial evaluating meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia. Phyther. Res. 19(10), 864–869 (2005).Crossref, Medline, CASGoogle Scholar
    • 111 Minich DM, Bland JS, Katke J et al. Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions. Can. J. Physiol. Pharmacol. 85(9), 872–883 (2007).Crossref, Medline, CASGoogle Scholar
    • 112 Rahimifard M, Navaei-Nigjeh M, Mahroui N et al. Improvement in the function of isolated rat pancreatic islets through reduction of oxidative stress using traditional Iranian medicine. Cell J. 16(2), 147–163 (2014).MedlineGoogle Scholar
    • 113 Tu Z, Moss-Pierce T, Ford P, Jiang TA. Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 cells. J. Agric. Food Chem. 61(11), 2803–2810 (2013).Crossref, Medline, CASGoogle Scholar
    • 114 Ozarowski M, Mikolajczak PL, Bogacz A et al. Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia. 91, 261–271 (2013).Crossref, Medline, CASGoogle Scholar
    • 115 Sasaki K, El Omri A, Kondo S, Han J, Isoda H. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav. Brain Res. 238, 86–94 (2013).Crossref, Medline, CASGoogle Scholar
    • 116 Machado DG, Cunha MP, Neis VB et al. Antidepressant-like effects of fractions, essential oil, carnosol and betulinic acid isolated from Rosmarinus officinalis L. Food Chem. 136(2), 999–1005 (2013).Crossref, Medline, CASGoogle Scholar
    • 117 El Omri A, Han J, Ben Abdrabbah M, Isoda H. Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells. Cytotechnology 64(3), 231–240 (2012).Crossref, MedlineGoogle Scholar
    • 118 Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR. Short-term study on the effects of rosemary on cognitive function in an elderly population. J. Med. Food. 15(1), 10–17 (2012).Crossref, MedlineGoogle Scholar
    • 119 Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Elsevier Health Sciences, Edinburgh, UK (2013).Google Scholar